Frank Griscelli

Title: Frank Griscelli: Innovator in Gene Therapy

Introduction

Frank Griscelli is a notable inventor based in Paris, France. He has made significant contributions to the field of gene therapy, particularly in the treatment of tumors. His innovative approach focuses on utilizing adenovirus vectors to deliver anti-angiogenic factors directly to tumor cells.

Latest Patents

Frank Griscelli holds a patent for "Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors." This invention relates to gene therapy aimed at inhibiting tumor growth and metastasis. Specifically, it involves the introduction of a gene encoding an anti-angiogenic factor into tumor cells using a defective adenovirus vector. The results of this method have shown a remarkable inhibition of neovascularization at the injection site, leading to reduced tumor growth and increased apoptosis of tumor cells.

Career Highlights

Griscelli is associated with Gencell Sas, where he continues to advance his research in gene therapy. His work has the potential to revolutionize cancer treatment by providing targeted therapies that minimize side effects and enhance efficacy.

Collaborations

Frank Griscelli has collaborated with notable colleagues, including Hong Li and He Lu. Their combined expertise contributes to the innovative research and development at Gencell Sas.

Conclusion

Frank Griscelli's contributions to gene therapy exemplify the potential of innovative approaches in treating complex diseases like cancer. His work continues to inspire advancements in medical science and offers hope for improved therapeutic strategies.